ResearcherHarvard UniversityActive in the last 2 years
Jelena Grahovac
Matched on ORCID iD 0000-0003-1430-8682; OpenAlex author ID A5011749534. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 5
- Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cells15111032↗
- Organoids, tissue slices and organotypic cultures: Advancing our understanding of pancreatic ductal adenocarcinoma through in vitro and ex vivo models. Co-author DOI 10.1016/j.semcancer.2024.12.003↗
- CRISPR/Cas9 genome engineering in PDAC: From preclinical studies to translation and clinical research. Co-author DOI 10.1016/j.semcancer.2025.07.004↗
- Sex-Related Differences in Pancreatic Ductal Adenocarcinoma Progression and Response to Therapy. Co-author DOI 10.3390/ijms252312669↗
- Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy. Co-author DOI 10.1158/2159-8290.cd-15-1177↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Maarten F. Bijlsma · 2 shared papers, 2025 · strength 0.53
- Paper Organoids, tissue slices and organotypic cultures: Advancing our understanding of pancreatic ductal adenocarcinoma thro… DOI 10.1016/j.semcancer.2024.12.003↗
- Paper CRISPR/Cas9 genome engineering in PDAC: From preclinical studies to translation and clinical research. DOI 10.1016/j.semcancer.2025.07.004↗
- Kristina Živić · 1 shared paper, 2026 · strength 0.33
- Tatjana Srdić-Rajić · 1 shared paper, 2026 · strength 0.33
- Ana Krivokuća · 1 shared paper, 2024 · strength 0.31
- Seçil Ak Aksoy · 1 shared paper, 2025 · strength 0.28
- Didem Karakaş · 1 shared paper, 2025 · strength 0.28
- Sıla Sığırlı · 1 shared paper, 2025 · strength 0.28
- Giulia Lencioni · 1 shared paper, 2025 · strength 0.28
- Julie Earl · 1 shared paper, 2025 · strength 0.28
- Yanxi Lu · 1 shared paper, 2025 · strength 0.25
- Naomi Walsh · 1 shared paper, 2025 · strength 0.25
- Jojanneke Stoof · 1 shared paper, 2025 · strength 0.25
- Robert Grützmann · 1 shared paper, 2025 · strength 0.25
- Tianhui Chen · 1 shared paper, 2025 · strength 0.25
- Christian P. Pilarsky · 1 shared paper, 2025 · strength 0.25
- Rakesh K. Jain · 1 shared paper, 2016 · strength 0.04
- João Incio · 1 shared paper, 2016 · strength 0.04
- Yves Boucher · 1 shared paper, 2016 · strength 0.04
- Keehoon Jung · 1 shared paper, 2016 · strength 0.04
- Theodoros P. Michelakos · 1 shared paper, 2016 · strength 0.04
- Nuh N. Rahbari · 1 shared paper, 2016 · strength 0.04
- Dai Fukumura · 1 shared paper, 2016 · strength 0.04
- Cristina Rosa Ferrone · 1 shared paper, 2016 · strength 0.04
- Hao Liu · 1 shared paper, 2016 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.